Evidence map›Paper›PMID 41473114›Full record

Trial reportFrontiers in veterinary science2025

A new highly digestible prescription diet containing

I Jeusette, E Apper, V Fragua, N Sanchez, C Torre, L Badiella, J Puig, E Ballester, A Jurado, L Feo Bernabe

Abstract readClinical Trial
In one paragraph

Trial report in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Functional Effects ofInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

I JeusetteR&D Department, Affinity Petcare, Barcelona, Spain.
E ApperR&D Department, Affinity Petcare, Barcelona, Spain.
V FraguaR&D Department, Affinity Petcare, Barcelona, Spain.
N SanchezImProVet, Barcelona, Spain.
C TorreR&D Department, Affinity Petcare, Barcelona, Spain.
L BadiellaMathematics Department, Autonomous University of Barcelona, Barcelona, Spain.
J PuigArs Veterinary Hospital, Barcelona, Spain.
E BallesterR&D Department, Affinity Petcare, Barcelona, Spain.
A JuradoR&D Department, Affinity Petcare, Barcelona, Spain.
L Feo BernabeArs Veterinary Hospital, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine if a newly formulated diet with safe and highly digestible ingredients, Hypothesis: The new diet (Diet B) will reduce the time to achieve normal fecal consistency compared to a highly digestible control (Diet A). Methods: Multicenter randomized, double-blinded, parallel-designed study with adult dogs with mild to moderate acute signs (less than 7 days) of uncomplicated diarrhea as inclusion criteria. Exclusion criteria were history of gastrointestinal signs, lack of correct vaccination and deworming, abnormal ultrasound examination, and previous administration of antibiotics, omeprazole or nutritional supplement. Response variables were compared using the appropriate bivariate test, time to recovery was analyzed using survival analysis techniques. Results: One hundred eleven dogs finished the study. Dogs fed Diet B ( Conclusion: Diet B resulted in faster clinical resolution, improved fecal consistency, frequency, odor and reduced incidence of dysbiosis compared to Diet A, making it a superior dietary approach in the management of mild acute diarrhea in dogs.

Indexed as

acute diarrheaanimal plasma proteinsdietdogprebioticsprobiotics

Identifiers

PMID41473114
PMCPMC12745240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.